Home / Import refusals / SCS-8406502-0/11/1

FDA Import Refusal SCS-8406502-0/11/1 — Kobayashi Pharmaceutical Co., Ltd.

Kobayashi Pharmaceutical Co., Ltd. — FEI 3005244965

The FDA refused shipment SCS-8406502-0/11/1 from Kobayashi Pharmaceutical Co., Ltd. (Japan) on December 19, 2021. The refused product falls under Drugs and Biologics — DICLOFENAC POTASSIUM (ANTI-INFLAMMATORY). Cited charges: 118,324,3280 This firm has 2 other import refusals on record.

Refusal Details

Date
December 19, 2021
Country
Japan
Product Category
Drugs and Biologics
Product Code
62GBY90 DICLOFENAC POTASSIUM (ANTI-INFLAMMATORY)
Charges
118,324,3280

Other import refusals

  • AEK-9448600-6/10002/1 (Fri Jun 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • FS2-2350254-3/11/1N (Tue Sep 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources